PULMATRIX, INC. Research and Development Expense
PULMATRIX, INC. (PULM) reported Research and Development Expense of $2.00 thousand for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-17
- PULMATRIX, INC. research and development expense for the quarter ending 2026-06-30 was $2.00K, a 85.71% decline year-over-year.
- PULMATRIX, INC. research and development expense for the quarter ending 2026-03-31 was $3.00K, a 84.21% decline year-over-year.
- PULMATRIX, INC. research and development expense for the quarter ending 2025-12-31 was -$3.00K, a 150.00% decline year-over-year.
- PULMATRIX, INC. research and development expense for the quarter ending 2025-09-30 was $8.00K, a 99.02% decline year-over-year.
- PULMATRIX, INC. research and development expense for fiscal 2023 was $15.52M, a 14.92% decline from fiscal 2022.
- PULMATRIX, INC. research and development expense for fiscal 2022 was $18.24M, a 18.58% increase from fiscal 2021.
- PULMATRIX, INC. research and development expense for fiscal 2021 was $15.38M, a 1.45% decline from fiscal 2020.
- PULMATRIX, INC. research and development expense for fiscal 2020 was $15.61M, a 21.52% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.00K S-4/A · filed 2026-09-17 | $5.00K S-4/A · filed 2026-09-17 | $2.00K derived: sum of 3 quarters · filed 2026-09-17 | $10.00K derived: sum of 4 quarters · filed 2026-09-17 | |
| 2026-03-31 | $3.00K S-4/A · filed 2026-08-03 | $0.00 derived: sum of 2 quarters · filed 2026-09-17 | $8.00K derived: sum of 3 quarters · filed 2026-09-17 | $22.00K derived: sum of 4 quarters · filed 2026-09-17 | |
| 2025-12-31 | -$3.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $5.00K derived: sum of 2 quarters · filed 2026-09-17 | $19.00K derived: sum of 3 quarters · filed 2026-09-17 | $38.00K S-4/A · filed 2026-09-17 | |
| 2025-09-30 | $8.00K 10-Q · filed 2025-10-16 | $22.00K derived: sum of 2 quarters · filed 2026-09-17 | $41.00K 10-Q · filed 2025-10-16 | $47.00K derived: sum of 4 quarters · filed 2026-09-17 | |
| 2025-06-30 | $14.00K S-4/A · filed 2026-09-17 | $33.00K S-4/A · filed 2026-09-17 | $39.00K derived: sum of 3 quarters · filed 2026-09-17 | $853.00K derived: sum of 4 quarters · filed 2026-09-17 | |
| 2025-03-31 | $19.00K S-4/A · filed 2026-08-03 | $25.00K derived: sum of 2 quarters · filed 2026-09-17 | $839.00K derived: sum of 3 quarters · filed 2026-09-17 | $3.67M derived: sum of 4 quarters · filed 2026-09-17 | |
| 2024-12-31 | $6.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $820.00K derived: sum of 2 quarters · filed 2026-09-17 | $3.65M derived: sum of 3 quarters · filed 2026-09-17 | $7.17M S-4/A · filed 2026-09-17 | |
| 2024-09-30 | $814.00K 10-Q · filed 2025-10-16 | $3.65M derived: sum of 2 quarters · filed 2025-10-16 | $7.16M 10-Q · filed 2025-10-16 | $10.68M derived: sum of 4 quarters · filed 2025-10-16 | |
| 2024-06-30 | $2.83M 10-Q · filed 2025-08-06 | $6.35M 10-Q · filed 2025-08-06 | $9.86M derived: sum of 3 quarters · filed 2025-08-06 | $13.82M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | $3.51M 10-Q · filed 2025-05-15 | $7.03M derived: sum of 2 quarters · filed 2025-05-15 | $10.99M derived: sum of 3 quarters · filed 2025-05-15 | $15.16M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $7.48M derived: sum of 2 quarters · filed 2025-03-21 | $11.64M derived: sum of 3 quarters · filed 2025-03-21 | $15.52M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $3.96M 10-Q · filed 2024-11-08 | $8.13M derived: sum of 2 quarters · filed 2024-11-08 | $12.00M 10-Q · filed 2024-11-08 | $16.47M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $4.17M 10-Q · filed 2024-08-13 | $8.04M 10-Q · filed 2024-08-13 | $12.51M derived: sum of 3 quarters · filed 2024-08-13 | $17.79M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $3.87M 10-Q · filed 2024-05-10 | $8.34M derived: sum of 2 quarters · filed 2024-05-10 | $13.63M derived: sum of 3 quarters · filed 2024-05-10 | $17.96M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $9.75M derived: sum of 2 quarters · filed 2024-03-28 | $14.09M derived: sum of 3 quarters · filed 2024-03-28 | $18.24M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $5.29M 10-Q · filed 2023-11-09 | $9.62M derived: sum of 2 quarters · filed 2023-11-09 | $13.77M 10-Q · filed 2023-11-09 | $16.73M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $4.34M 10-Q · filed 2023-08-10 | $8.49M 10-Q · filed 2023-08-10 | $11.45M derived: sum of 3 quarters · filed 2023-08-10 | $15.47M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $4.15M 10-Q · filed 2023-05-12 | $7.11M derived: sum of 2 quarters · filed 2023-05-12 | $11.13M derived: sum of 3 quarters · filed 2023-05-12 | $15.68M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $6.99M derived: sum of 2 quarters · filed 2023-03-30 | $11.53M derived: sum of 3 quarters · filed 2023-03-30 | $15.38M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $4.03M 10-Q · filed 2022-11-10 | $8.57M derived: sum of 2 quarters · filed 2022-11-10 | $12.42M 10-Q · filed 2022-11-10 | $15.69M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $4.54M 10-Q · filed 2022-08-10 | $8.40M 10-Q · filed 2022-08-10 | $11.66M derived: sum of 3 quarters · filed 2022-08-10 | $15.54M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $3.86M 10-Q · filed 2022-05-12 | $7.12M derived: sum of 2 quarters · filed 2022-05-12 | $10.99M derived: sum of 3 quarters · filed 2022-05-12 | $14.18M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $7.14M derived: sum of 2 quarters · filed 2022-03-29 | $10.32M derived: sum of 3 quarters · filed 2022-03-29 | $15.61M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $3.87M 10-Q · filed 2021-11-10 | $7.06M derived: sum of 2 quarters · filed 2021-11-10 | $12.34M 10-Q · filed 2021-11-10 | $16.55M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.18M 10-Q · filed 2021-08-10 | $8.47M 10-Q · filed 2021-08-10 | $12.68M derived: sum of 3 quarters · filed 2021-08-10 | $15.98M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | $5.29M 10-Q · filed 2021-05-11 | $9.49M derived: sum of 2 quarters · filed 2021-05-11 | $12.79M derived: sum of 3 quarters · filed 2021-05-11 | $15.96M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $7.50M derived: sum of 2 quarters · filed 2021-03-23 | $10.67M derived: sum of 3 quarters · filed 2021-03-23 | $12.85M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $3.30M 10-Q · filed 2020-11-12 | $6.46M derived: sum of 2 quarters · filed 2020-11-12 | $8.64M 10-Q · filed 2020-11-12 | $11.86M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $3.16M 10-Q · filed 2020-08-07 | $5.34M 10-Q · filed 2020-08-07 | $8.56M derived: sum of 3 quarters · filed 2020-08-07 | $11.62M derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | $2.18M 10-Q · filed 2020-05-14 | $5.40M derived: sum of 2 quarters · filed 2020-05-14 | $8.45M derived: sum of 3 quarters · filed 2020-05-14 | $12.47M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $3.22M 10-Q · filed 2019-05-15 | $6.28M derived: sum of 2 quarters · filed 2019-11-01 | $10.29M derived: sum of 3 quarters · filed 2019-11-01 | $12.97M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $3.06M 10-Q · filed 2019-11-01 | $7.07M derived: sum of 2 quarters · filed 2019-11-01 | $10.29M 10-Q · filed 2019-11-01 | $12.88M derived: sum of 4 quarters · filed 2019-11-01 | |
| 2018-06-30 | $4.01M 10-Q · filed 2019-08-05 | $7.23M 10-Q · filed 2019-08-05 | $9.82M derived: sum of 3 quarters · filed 2019-08-05 | $12.44M derived: sum of 4 quarters · filed 2019-08-05 | |
| 2018-03-31 | $3.22M 10-Q · filed 2018-05-11 | $5.81M derived: sum of 2 quarters · filed 2019-02-19 | $8.43M derived: sum of 3 quarters · filed 2019-02-19 | $11.79M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $5.21M derived: sum of 2 quarters · filed 2019-02-19 | $8.57M derived: sum of 3 quarters · filed 2019-02-19 | $10.24M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $2.62M 10-Q · filed 2018-11-14 | $5.98M derived: sum of 2 quarters · filed 2018-11-14 | $7.65M 10-Q · filed 2018-11-14 | $10.43M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $3.36M 10-Q · filed 2018-08-03 | $5.04M 10-Q · filed 2018-08-03 | $7.81M derived: sum of 3 quarters · filed 2018-08-03 | $9.32M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $1.67M 10-Q · filed 2018-05-11 | $4.45M derived: sum of 2 quarters · filed 2018-05-11 | $5.95M derived: sum of 3 quarters · filed 2018-05-11 | $8.39M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $4.28M derived: sum of 2 quarters · filed 2018-03-13 | $6.72M derived: sum of 3 quarters · filed 2018-03-13 | $10.15M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $1.51M 10-Q · filed 2017-11-09 | $3.95M derived: sum of 2 quarters · filed 2017-11-09 | $7.38M 10-Q · filed 2017-11-09 | $9.84M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $2.44M 10-Q · filed 2017-08-04 | $5.87M 10-Q · filed 2017-08-04 | $8.34M derived: sum of 3 quarters · filed 2017-08-04 | $10.53M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $3.43M 10-Q · filed 2017-05-05 | $5.90M derived: sum of 2 quarters · filed 2017-05-05 | $8.09M derived: sum of 3 quarters · filed 2017-05-05 | $9.70M derived: sum of 4 quarters · filed 2017-05-05 | |
| 2015-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $4.66M derived: sum of 2 quarters · filed 2017-03-10 | $6.27M derived: sum of 3 quarters · filed 2017-03-10 | $7.19M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $2.19M 10-Q · filed 2016-11-04 | $3.80M derived: sum of 2 quarters · filed 2016-11-04 | $4.72M 10-Q · filed 2016-11-04 | $5.34M derived: sum of 4 quarters · filed 2016-11-04 | |
| 2015-06-30 | $1.61M 10-Q · filed 2016-08-04 | $2.53M 10-Q · filed 2016-08-04 | $3.15M derived: sum of 3 quarters · filed 2016-08-04 | $5.08M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | $918.00K 10-Q · filed 2016-05-05 | $1.54M derived: sum of 2 quarters · filed 2016-05-05 | $3.47M derived: sum of 3 quarters · filed 2016-05-05 | $2.18M 10-K · filed 2015-06-10 | |
| 2014-12-31 | $619.00K 10-Q · filed 2015-02-13 | $2.55M derived: sum of 2 quarters · filed 2015-11-12 | $1.92M 10-Q · filed 2015-02-13 | $6.59M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $1.93M 10-Q · filed 2015-11-12 | $629.00K 10-Q · filed 2014-11-13 | $1.30M 10-Q · filed 2014-11-13 | $5.42M 10-Q · filed 2015-11-12 | $4.37M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $1.73M 10-Q · filed 2015-08-14 | $676.00K 10-Q · filed 2014-08-14 | $3.49M 10-Q · filed 2015-08-14 | $2.44M derived: sum of 3 quarters · filed 2015-08-14 | $2.94M derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $712.00K derived: sum of 2 quarters · filed 2015-06-10 | $1.21M derived: sum of 3 quarters · filed 2015-06-10 | $1.38M 10-K · filed 2015-06-10 | |
| 2013-12-31 | $395.00K 10-Q · filed 2015-02-13 | $890.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.06M 10-Q · filed 2015-02-13 | ||
| 2013-09-30 | $495.00K 10-Q · filed 2014-11-13 | $670.00K 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $175.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |